Oncology and the heart
Given our chemotherapy, radiation therapy, and the advent of immune checkpoint inhibitors, oncology and cardiology may be more closely linked than ever before. This interview reviews the potential toxicities of today's radiation, chemotherapy, immunotherapy, and the structural involvement that tumors may cause in and around the heart. Although the immune checkpoint inhibitors are not commonly associated with cardiac toxicity, their increasing use may tell us otherwise. This interview summarizes the close association between oncology and cardiology, which we should bear in mind as we treat our patients.
Correspondence David H Henry, MD; David.Henry@uphs.upenn.edu.
Disclosures The authors report no disclosures/conflicts of interest.
Citation JCSO 2017;15(3):e178-e182
©2017 Frontline Medical Communications
doi https://doi.org/10.12788/jcso.0348
Related articles
Sarcoidosis, complete heart block, and warm autoimmune hemolytic anemia
An unusual case of primary cardiac prosthetic valve-associated lymphoma
Submit a paper here
